Sudeep Pharma plans to raise ₹95 crore for capex and expand manufacturing capacity by 50,000 tonnes by March 2026. Despite strong export revenue and profit growth, investors may await post-listing performance due to high customer concentration and increased working capital days. The company seeks a P/E multiple of up to 48.
FIIs sold about Rs 11,000 crore worth Indian stocks in 2 days of US-Iran war
Foreign investors sold nearly Rs 11,000 crore in two March sessions amid escalating West Asia tensions, surging crude prices and currency volatility. DIIs offered support,